Results 61 to 70 of about 78,184 (307)

Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus

open access: yesFrontiers in Medicine, 2021
Bruton Tyrosine Kinase (BTK) has a key role in multiple pathways involved in inflammation and autoimmunity. Therefore, BTK has become a new therapeutic target for a group of hematologic and autoimmune disorders.
Aikaterini Patsatsi, Dedee F. Murrell
doaj   +1 more source

Investigation of the superconducting energy gap in the compound LuNi$_{2}$B$_{2}$C by the method of point contact spectroscopy: two-gap approximation [PDF]

open access: yes, 2005
It is shown that the two-gap approximation is applicable for describing the $dV/dI(V)$ spectra of LuNi$_{2}$B$_{2}$C-Ag point contacts in a wide interval of temperatures.
Beloborod'ko, S. I.   +6 more
core   +2 more sources

Inverting the BTK-BCL2 order [PDF]

open access: yesBlood, 2020
In this issue of Blood, Lin et al report the first long-term follow-up data showing that Bruton tyrosine kinase inhibitors (BTKi's) are effective in chronic lymphocytic leukemia (CLL) after previous progression on venetoclax.
openaire   +2 more sources

BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects

open access: yesFrontiers in Immunology, 2021
Bruton´s tyrosine kinase (BTK) inhibitor (BTKi)s block the B-cell receptor (BCR) signaling cascade by binding to the BTK enzyme preventing the proliferation and survival of malignant and normal B cells.
M. Palma, T. Mulder, A. Österborg
semanticscholar   +1 more source

Inactivating BTK mutations in large B‐cell lymphoma in a real‐world cohort: Strong correlation with BCL2 translocation

open access: yeseJHaem, 2022
Inactivating mutations in Bruton's tyrosine kinase (BTK) in patients with follicular lymphoma (FL) have recently been reported. These mutations were found in BTK inhibitor‐treatment naïve patients.
Lone Schejbel   +6 more
doaj   +1 more source

Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms

open access: yesInternational Journal of Molecular Sciences
The B cell receptor (BCR) signaling pathway plays a crucial role in B cell development and contributes to the pathogenesis of B cell neoplasms. In B cell malignancies, the BCR is constitutively active through both ligand-dependent and ligand-independent ...
S. Mouhssine   +4 more
semanticscholar   +1 more source

The tyrosine kinase Btk regulates the macrophage response to Listeria monocytogenes infection.

open access: yesPLoS ONE, 2013
In this study we investigated the role of Bruton's tyrosine kinase (Btk) in the immune response to the Gram-positive intracellular bacterium Listeria monocytogenes (Lm).
Afitap Derya Köprülü   +12 more
doaj   +1 more source

Bruton’s Tyrosine Kinase-Mediated Signaling in Myeloid Cells Is Required for Protective Innate Immunity During Pneumococcal Pneumonia

open access: yesFrontiers in Immunology, 2021
Bruton’s tyrosine kinase (Btk) is a cytoplasmic kinase expressed in B cells and myeloid cells. It is essential for B cell development and natural antibody-mediated host defense against bacteria in humans and mice, but little is known about the role of ...
Alexander P. de Porto   +16 more
doaj   +1 more source

Theory of electron transport in normal metal/superconductor junctions [PDF]

open access: yes, 2000
On the basis of the Keldysh method of non-equilibrium systems, we develop a theory of electron tunneling in normal-metal/superconductor junctions. By using the tunneling Hamiltonian model (being appropriate for the tight-binding systems), the tunneling ...
Hu, Chia-Ren   +2 more
core   +2 more sources

BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair

open access: yesActa Neuropathologica
In multiple sclerosis (MS), persisting disability can occur independent of relapse activity or development of new central nervous system (CNS) inflammatory lesions, termed chronic progression.
Anastasia Geladaris   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy